Himanshu Praful Ranvah's most recent trade in J B Chemicals & Pharmaceuticals Ltd. was a Disposal of 400 Equity Shares done at an average price of Rs. 1810 . Disclosure was reported to the exchange on Jan. 6, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Himanshu Praful Ranvah in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Disposal | 06 Jan 2025 | 400 | 0 (0%) | 0.00% | 1810 | 724,000 | 30 Dec 2024 30 Dec 2024 |
Insider Trading | Equity Shares | Market Sale |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Disposal | 19 Dec 2024 | 2,000 | 0 (0%) | 0.00% | 1832.5 | 3,665,000 | 12 Dec 2024 12 Dec 2024 |
Insider Trading | Equity Shares | Market Sale |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Disposal | 19 Dec 2024 | 2,000 | 0 (0%) | 0.00% | 1832.5 | 3,665,000 | 12 Dec 2024 12 Dec 2024 |
Insider Trading | Equity Shares | Market Sale |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Acquisition | 19 Dec 2024 | 400 | 400 (0%) | 0.00% | 1855.8 | 742,320 | 18 Dec 2024 18 Dec 2024 |
Insider Trading | Equity Shares | ESOP |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Acquisition | 19 Dec 2024 | 400 | 400 (0%) | 0.00% | 1855.8 | 742,320 | 18 Dec 2024 18 Dec 2024 |
Insider Trading | Equity Shares | ESOP |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Acquisition | 09 Dec 2024 | 2,000 | 2,000 (0%) | 0.00% | 1764.0 | 3,527,900 | 06 Dec 2024 06 Dec 2024 |
Insider Trading | Equity Shares | ESOP |
J B Chemicals | Himanshu Praful Ranvah | Designated Person | Acquisition | 09 Dec 2024 | 2,000 | 2,000 (0%) | 0.00% | 1764.0 | 3,527,900 | 06 Dec 2024 06 Dec 2024 |
Insider Trading | Equity Shares | ESOP |